US 9487535
Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
granted A61PA61P25/00
Quick answer
US patent 9487535 (Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P25/00